Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 7VZT | P0DTC2 | A human neutralizing antibody targeting SARS-CoV-2 RBD | |
| 8H07 | P0DTC2 | SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H07 | P0DTC2 | SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H08 | P0DTC2 | SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H08 | P0DTC2 | SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 7Y6L | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab816 | |
| 7Y6N | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab803 | |
| 8EPN | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike trimer S2D14 in the 3-RBD Down conformation | |
| 8EPP | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike trimer S2D14 with two RBDs in the open conformation | |
| 8EPQ | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike trimer S2D14 with two RBDs exposed | |
| 8IDN | P0DTC2 | Cryo-EM structure of RBD/E77-Fab complex | |
| 8J1Q | P0DTC2 | CryoEM structure of SARS CoV-2 RBD and Aptamer complex | |
| 8J26 | P0DTC2 | CryoEM structure of SARS CoV-2 RBD and Aptamer complex | |
| 7YVE | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH027 Fab | |
| 7YVG | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH132 Fab | |
| 7YVI | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH236 Fab | |
| 7YVK | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH272 Fab | |
| 7YVN | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH281 Fab | |
| 7YVO | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH027/132 Fab | |
| 7YVP | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH272/281 Fab | |
| 8BON | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the macrocyclic peptide S1B3inL1 | |
| 8E1G | P0DTC2 | SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 | |
| 8GOU | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH003 Fab | |
| 8SMT | P0DTC2 | Crystal structure of antibody WRAIR-2134 in complex with SARS-CoV-2 receptor binding domain | |
| 8EQF | P0DTC2 | cryoEM structure of a broadly neutralizing anti-SARS-CoV-2 antibody STI-9167 | |
| 8U1G | P0DTC2 | Prefusion-stabilized SARS-CoV-2 S2 subunit | |
| 8CBD | P0DTC2 | SARS-CoV-2 Delta-RBD complexed with BA.4/5-1 and EY6A Fabs | |
| 8CBE | P0DTC2 | SARS-CoV-2 Delta-RBD complexed with BA.4/5-2 and Beta-49 Fabs | |
| 8CBF | P0DTC2 | SARS-CoV-2 Delta-RBD complexed with Omi-42 and Beta-49 Fabs | |
| 8I9B | P0DTC2 | S-ECD (Omicron BA.2.75) in complex with PD of ACE2 | |
| 8I9C | P0DTC2 | S-ECD (Omicron BF.7) in complex with PD of ACE2 | |
| 8I9D | P0DTC2 | S-ECD (Omicron XBB.1) in complex with PD of ACE2 | |
| 8I9E | P0DTC2 | S-RBD(Omicron BA.3) in complex with PD of ACE2 | |
| 8I9F | P0DTC2 | S-RBD (Omicron BA.2.75) in complex with PD of ACE2 | |
| 8I9G | P0DTC2 | S-RBD (Omicron BF.7) in complex with PD of ACE2 | |
| 8I9H | P0DTC2 | S-RBD (Omicron XBB.1) in complex with PD of ACE2 | |
| 8TYL | P0DTC2 | Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2 | |
| 8TYO | P0DTC2 | Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2 | |
| 8GDR | P0DTC2 | SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21B10 | |
| 8R1C | P0DTC2 | SD1-2 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein | |
| 8R1D | P0DTC2 | SD1-3 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein | |
| 8SDF | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4 | |
| 8SDG | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.43 | |
| 8SIQ | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab | |
| 8SIR | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC25.54 Fab | |
| 8SIS | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.2 Fab | |
| 8SIT | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.24 Fab | |
| 8VQR | P0DTC2 | Crystal structure of chimeric SARS-CoV-2 RBD complexed with chimeric raccoon dog ACE2 | |
| 8UIR | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-XBB.1.16) | |
| 8UK1 | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer consensus (S-RRAR-Omicron-XBB.1.16) |
